Vincerx Pharma Shares Outstanding 2020-2024 | VINC

Vincerx Pharma shares outstanding from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Vincerx Pharma Shares Outstanding 2020-2024 | VINC

Vincerx Pharma shares outstanding from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$173B
Vertex Pharmaceuticals (VRTX)$129.4B
Gilead Sciences (GILD)$121.9B
Bristol Myers Squibb (BMY)$111B
CSL (CSLLY)$91.9B
Regeneron Pharmaceuticals (REGN)$90.6B
GSK (GSK)$76B
Argenex SE (ARGX)$35.4B
Alnylam Pharmaceuticals (ALNY)$35.1B
BioNTech SE (BNTX)$25.7B
Biogen (BIIB)$25.3B
Illumina (ILMN)$24.6B
BeiGene (BGNE)$20.1B
Moderna (MRNA)$19.3B
Incyte (INCY)$15.9B
Genmab (GMAB)$15.3B
Insmed (INSM)$12.8B
Vaxcyte (PCVX)$12.8B
BioMarin Pharmaceutical (BMRN)$12.8B
Bio-Techne Corp (TECH)$12.1B
Sarepta Therapeutics (SRPT)$11.5B
Exelixis (EXEL)$10.2B
QIAGEN (QGEN)$10.1B
Revolution Medicines (RVMD)$9.9B
Exact Sciences (EXAS)$9.9B
Intra-Cellular Therapies (ITCI)$9.6B
Bio-Rad Laboratories (BIO.B)$9.4B
Roivant Sciences (ROIV)$8.7B
Repligen (RGEN)$8.1B
Ascendis Pharma (ASND)$7.7B